Advertisement

TheBodyPRO.com Covers CROI 2017

News

Seattle-lite: Pre-Conference Workshops -- Watch Online

February 14, 2017

The commitment to providing all presentations online as open access educational resources is one of the most impressive aspect of the annual CROI meetings.

Options include to watch the presentations with slide, download audio only or as podcasts, pause, repeat, enlarge slides to catch the details -- and that the programme become available within 24 hours of the presentations.

And every year, before the main conference, state-or-the-art lectures provide sharp overviews of key subjects. Each lecture reviews current knowledge on the subject and set the background for the new research that will presented during the main conference.

So these lectures are already online -- and are an excellent way to spend an hour or two to sharpen your knowledge.

This year's programme is listed below. Pick your favourite and click a link.
www.croiwebcasts.org


Advertisement

Workshop 1: Science and Cure

  • Molecular virology: Understanding HIV -- Paul Bieniasz
  • Advances in antibodies -- Richard Koup
  • Advances in prevention -- James McIntyre
  • HIV complications -- Judith Currier
  • HIV reservoirs: obstacles to a cure -- Nicolas Chomont


Martin Delaney Lecture: Good Practice in Research and Involving the Community

  • History and principles of good practice -- Stacey Hannah
  • Good practice in prevention trials -- Deborah Baron
  • Good practice in cure trials -- David Evans


Workshop 2 Clinical Trial Design

  • Prevention trials in the PrEP era -- Deborah Donnell
  • Implementation of trials -- 
James R. Hargreaves
  • Recruiting hard to reach populations -- Carl A. Latkin


Workshop 3: Frontiers in Lab Science

  • High throughput genome engineering -- Judd Hultquist
  • Identifying and profiling virus-specific T cells -- 
Evan William Newell
  • Quantifying HIV-1 MRNA structure -- Silvi Rouskin


Workshop 4: Hepatitis C -- Interactive Case Studies

  • Staging and treatment of early stage HCV -- John Scott
  • Resistance to DAAs and retreatment of chronic HCV -- Alessandra Mangia
  • Common drug interactions with DAAs -- Debika Bhattacharya
  • Issues with cirrhosis -- 



Sanjay Bhagani


Related Stories

CROI 2017 Preview: New Research on HIV Cure and Treatment
Bictegravir versus Dolutegravir: Phase 2 Results of New Integrase Inhibitor
Antibodies Could Offer a More 'Natural' and Safer HIV Treatment or Prevention Option



This article was provided by HIV i-Base. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections. Visit HIV i-Base's website to find out more about their activities, publications and services.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.